Report cover image

Cancer Diagnosis

Publisher Cognitive Market Research
Published Mar 01, 2026
SKU # COG21171303

Description

According to Cognitive Market Research, the global Cancer Diagnosis market size was USD 109614.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 43845.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

Europe accounted for a market share of over 30% of the global revenue with a market size of USD 32884.35 million.

Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 25211.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Latin America had a market share of more than 5% of the global revenue with a market size of USD 5480.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2192.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

The consumables category is the fastest growing segment of the Cancer Diagnosis industry

Table of Contents

Chapter 1 2026 Geopolitical Outlook - Cancer Diagnosis Market Detailed Analysis
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
Chapter 3 Global Market Analysis
3.1 Global Cancer Diagnosis Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global Cancer Diagnosis Market Size By Regions 2022 - 2034
3.2.1 Global Cancer Diagnosis Revenue Market Size By Region
3.3 Global Cancer Diagnosis Market Size By Type Outlook: 2022 - 2034
3.3.1 Consumables Market Size
3.3.2 Instruments Market Size
3.4 Global Cancer Diagnosis Market Size By Application Outlook: 2022 - 2034
3.4.1 Breast Cancer Market Size
3.4.2 Lung Cancer Market Size
3.4.3 Colorectal Cancer Market Size
3.4.4 Melanoma Market Size
3.4.5 Other Cancers Market Size
3.5 Global Cancer Diagnosis Market Size By Technology Outlook: 2022 - 2034
3.5.1 IVD Testing Market Size
3.5.2 Biopsy Technique Market Size
3.5.3 Imaging Market Size
3.6 Global Cancer Diagnosis Market Size By End User Outlook: for 2022 - 2034
3.6.1 Hospitals Market Size
3.6.2 Diagnostic Laboratories Market Size
3.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
3.8 Executive Summary Global Market (2021 vs 2025 vs 2033)
3.8.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
3.8.2 Global Market Revenue Split By Type Outlook:
3.8.3 Global Market Revenue Split By Application Outlook:
3.8.4 Global Market Revenue Split By Technology Outlook:
3.8.5 Global Market Revenue Split By End User Outlook:
3.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Chapter 4 North America Market Analysis
4.1 North America Cancer Diagnosis Market Outlook
4.1.1 North America Cancer Diagnosis Market Size 2022 - 2034
4.1.2 North America Cancer Diagnosis Market Size By Country 2022 - 2034
4.1.3 North America Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
4.1.3.1 North America Consumables Market Size
4.1.3.2 North America Instruments Market Size
4.1.4 North America Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
4.1.4.1 North America Breast Cancer Market Size
4.1.4.2 North America Lung Cancer Market Size
4.1.4.3 North America Colorectal Cancer Market Size
4.1.4.4 North America Melanoma Market Size
4.1.4.5 North America Other Cancers Market Size
4.1.5 North America Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
4.1.5.1 North America IVD Testing Market Size
4.1.5.2 North America Biopsy Technique Market Size
4.1.5.3 North America Imaging Market Size
4.1.6 North America Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
4.1.6.1 North America Hospitals Market Size
4.1.6.2 North America Diagnostic Laboratories Market Size
Chapter 5 Europe Market Analysis
5.1 Europe Cancer Diagnosis Market Outlook
5.1.1 Europe Cancer Diagnosis Market Size 2022 - 2034
5.1.2 Europe Cancer Diagnosis Market Size By Country 2022 - 2034
5.1.3 Europe Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
5.1.3.1 Europe Consumables Market Size
5.1.3.2 Europe Instruments Market Size
5.1.4 Europe Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
5.1.4.1 Europe Breast Cancer Market Size
5.1.4.2 Europe Lung Cancer Market Size
5.1.4.3 Europe Colorectal Cancer Market Size
5.1.4.4 Europe Melanoma Market Size
5.1.4.5 Europe Other Cancers Market Size
5.1.5 Europe Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
5.1.5.1 Europe IVD Testing Market Size
5.1.5.2 Europe Biopsy Technique Market Size
5.1.5.3 Europe Imaging Market Size
5.1.6 Europe Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
5.1.6.1 Europe Hospitals Market Size
5.1.6.2 Europe Diagnostic Laboratories Market Size
Chapter 6 Asia Pacific Market Analysis
6.1 Asia Pacific Cancer Diagnosis Market Outlook
6.1.1 Asia Pacific Cancer Diagnosis Market Size 2022 - 2034
6.1.2 Asia Pacific Cancer Diagnosis Market Size By Country 2022 - 2034
6.1.3 Asia Pacific Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
6.1.3.1 Asia Pacific Consumables Market Size
6.1.3.2 Asia Pacific Instruments Market Size
6.1.4 Asia Pacific Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
6.1.4.1 Asia Pacific Breast Cancer Market Size
6.1.4.2 Asia Pacific Lung Cancer Market Size
6.1.4.3 Asia Pacific Colorectal Cancer Market Size
6.1.4.4 Asia Pacific Melanoma Market Size
6.1.4.5 Asia Pacific Other Cancers Market Size
6.1.5 Asia Pacific Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
6.1.5.1 Asia Pacific IVD Testing Market Size
6.1.5.2 Asia Pacific Biopsy Technique Market Size
6.1.5.3 Asia Pacific Imaging Market Size
6.1.6 Asia Pacific Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
6.1.6.1 Asia Pacific Hospitals Market Size
6.1.6.2 Asia Pacific Diagnostic Laboratories Market Size
Chapter 7 South America Market Analysis
7.1 South America Cancer Diagnosis Market Outlook
7.1.1 South America Cancer Diagnosis Market Size 2022 - 2034
7.1.2 South America Cancer Diagnosis Market Size By Country 2022 - 2034
7.1.3 South America Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
7.1.3.1 South America Consumables Market Size
7.1.3.2 South America Instruments Market Size
7.1.4 South America Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
7.1.4.1 South America Breast Cancer Market Size
7.1.4.2 South America Lung Cancer Market Size
7.1.4.3 South America Colorectal Cancer Market Size
7.1.4.4 South America Melanoma Market Size
7.1.4.5 South America Other Cancers Market Size
7.1.5 South America Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
7.1.5.1 South America IVD Testing Market Size
7.1.5.2 South America Biopsy Technique Market Size
7.1.5.3 South America Imaging Market Size
7.1.6 South America Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
7.1.6.1 South America Hospitals Market Size
7.1.6.2 South America Diagnostic Laboratories Market Size
Chapter 8 Middle East Market Analysis
8.1 Middle East Cancer Diagnosis Market Outlook
8.1.1 Middle East Cancer Diagnosis Market Size 2022 - 2034
8.1.2 Middle East Cancer Diagnosis Market Size By Country 2022 - 2034
8.1.3 Middle East Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
8.1.3.1 Middle East Consumables Market Size
8.1.3.2 Middle East Instruments Market Size
8.1.4 Middle East Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
8.1.4.1 Middle East Breast Cancer Market Size
8.1.4.2 Middle East Lung Cancer Market Size
8.1.4.3 Middle East Colorectal Cancer Market Size
8.1.4.4 Middle East Melanoma Market Size
8.1.4.5 Middle East Other Cancers Market Size
8.1.5 Middle East Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
8.1.5.1 Middle East IVD Testing Market Size
8.1.5.2 Middle East Biopsy Technique Market Size
8.1.5.3 Middle East Imaging Market Size
8.1.6 Middle East Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
8.1.6.1 Middle East Hospitals Market Size
8.1.6.2 Middle East Diagnostic Laboratories Market Size
Chapter 9 Africa Market Analysis
9.1 Africa Cancer Diagnosis Market Outlook
9.1.1 Africa Cancer Diagnosis Market Size 2022 - 2034
9.1.2 Africa Cancer Diagnosis Market Size By Country 2022 - 2034
9.1.3 Africa Cancer Diagnosis Market Size by Type Outlook: 2022 - 2034
9.1.3.1 Africa Consumables Market Size
9.1.3.2 Africa Instruments Market Size
9.1.4 Africa Cancer Diagnosis Market Size by Application Outlook: 2022 - 2034
9.1.4.1 Africa Breast Cancer Market Size
9.1.4.2 Africa Lung Cancer Market Size
9.1.4.3 Africa Colorectal Cancer Market Size
9.1.4.4 Africa Melanoma Market Size
9.1.4.5 Africa Other Cancers Market Size
9.1.5 Africa Cancer Diagnosis Market Size by Technology Outlook: 2022 - 2034
9.1.5.1 Africa IVD Testing Market Size
9.1.5.2 Africa Biopsy Technique Market Size
9.1.5.3 Africa Imaging Market Size
9.1.6 Africa Cancer Diagnosis Market Size by End User Outlook: 2022 - 2034
9.1.6.1 Africa Hospitals Market Size
9.1.6.2 Africa Diagnostic Laboratories Market Size
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
10.1 Top Competitors Analysis
10.1.1 Global Cancer Diagnosis Market Revenue and Share by Key Players
10.1.2 Top Players Ranking 2024
10.1.3 New Product Launch Analysis
10.1.4 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
10.2.1 Roche Diagnostics
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.1.2 Business Overview
10.2.1.3 Financials (Subject to data availability)
10.2.1.4 R&D Investment (Subject to data availability)
10.2.1.5 Product Types Specification
10.2.1.6 Business Strategy
10.2.1.7 Recent Developments
10.2.1.8 Management Change
10.2.1.9 S.W.O.T Analysis
10.2.2 Abbott
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.2.2 Business Overview
10.2.2.3 Financials (Subject to data availability)
10.2.2.4 R&D Investment (Subject to data availability)
10.2.2.5 Product Types Specification
10.2.2.6 Business Strategy
10.2.2.7 Recent Developments
10.2.2.8 Management Change
10.2.2.9 S.W.O.T Analysis
10.2.3 QIAGEN
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.3.2 Business Overview
10.2.3.3 Financials (Subject to data availability)
10.2.3.4 R&D Investment (Subject to data availability)
10.2.3.5 Product Types Specification
10.2.3.6 Business Strategy
10.2.3.7 Recent Developments
10.2.3.8 Management Change
10.2.3.9 S.W.O.T Analysis
10.2.4 BD
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.4.2 Business Overview
10.2.4.3 Financials (Subject to data availability)
10.2.4.4 R&D Investment (Subject to data availability)
10.2.4.5 Product Types Specification
10.2.4.6 Business Strategy
10.2.4.7 Recent Developments
10.2.4.8 Management Change
10.2.4.9 S.W.O.T Analysis
10.2.5 F. Hoffmann-La Roche Ltd.
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.5.2 Business Overview
10.2.5.3 Financials (Subject to data availability)
10.2.5.4 R&D Investment (Subject to data availability)
10.2.5.5 Product Types Specification
10.2.5.6 Business Strategy
10.2.5.7 Recent Developments
10.2.5.8 Management Change
10.2.5.9 S.W.O.T Analysis
10.2.6 GE Healthcare
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.6.2 Business Overview
10.2.6.3 Financials (Subject to data availability)
10.2.6.4 R&D Investment (Subject to data availability)
10.2.6.5 Product Types Specification
10.2.6.6 Business Strategy
10.2.6.7 Recent Developments
10.2.6.8 Management Change
10.2.6.9 S.W.O.T Analysis
10.2.7 Koninklijke Philips N.V. (Philips)
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.7.2 Business Overview
10.2.7.3 Financials (Subject to data availability)
10.2.7.4 R&D Investment (Subject to data availability)
10.2.7.5 Product Types Specification
10.2.7.6 Business Strategy
10.2.7.7 Recent Developments
10.2.7.8 Management Change
10.2.7.9 S.W.O.T Analysis
10.2.8 Thermo Fisher Scientific Inc.
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.8.2 Business Overview
10.2.8.3 Financials (Subject to data availability)
10.2.8.4 R&D Investment (Subject to data availability)
10.2.8.5 Product Types Specification
10.2.8.6 Business Strategy
10.2.8.7 Recent Developments
10.2.8.8 Management Change
10.2.8.9 S.W.O.T Analysis
10.2.9 Illumina Inc.
10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.9.2 Business Overview
10.2.9.3 Financials (Subject to data availability)
10.2.9.4 R&D Investment (Subject to data availability)
10.2.9.5 Product Types Specification
10.2.9.6 Business Strategy
10.2.9.7 Recent Developments
10.2.9.8 Management Change
10.2.9.9 S.W.O.T Analysis
10.2.10 Siemens Healthcare GmbH
10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.10.2 Business Overview
10.2.10.3 Financials (Subject to data availability)
10.2.10.4 R&D Investment (Subject to data availability)
10.2.10.5 Product Types Specification
10.2.10.6 Business Strategy
10.2.10.7 Recent Developments
10.2.10.8 Management Change
10.2.10.9 S.W.O.T Analysis
10.2.11 Hologic Inc.
10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.11.2 Business Overview
10.2.11.3 Financials (Subject to data availability)
10.2.11.4 R&D Investment (Subject to data availability)
10.2.11.5 Product Types Specification
10.2.11.6 Business Strategy
10.2.11.7 Recent Developments
10.2.11.8 Management Change
10.2.11.9 S.W.O.T Analysis
Chapter 11 Qualitative Analysis (Subject to Data Availability)
11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Consumer Preference Analysis
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
11.9.1 Political Factors
11.9.2 Economic Factors
11.9.3 Social Factors
11.9.4 Technological Factors
11.9.5 Legal Factors
11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
11.10.1 Industry Chain Analysis
11.10.2 Manufacturing Cost Analysis
11.10.3 Supply Side Analysis
11.10.3.1 Raw Material Analysis
11.10.3.2 Raw Material Procurement Analysis
11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
11.11.1 Bargaining Power of Suppliers
11.11.2 Bargaining Power of Buyers
11.11.3 Threat of New Entrants
11.11.4 Threat of Substitutes
11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis
Chapter 12 Market Split by Type Outlook: Analysis 2022 - 2034
12.1 Consumables
12.1.1 Global Cancer Diagnosis Revenue Market Size and Share by Consumables 2022 - 2034
12.2 Instruments
12.2.1 Global Cancer Diagnosis Revenue Market Size and Share by Instruments 2022 - 2034
Chapter 13 Market Split by Application Outlook: Analysis 2022 - 2034
13.1 Breast Cancer
13.1.1 Global Cancer Diagnosis Revenue Market Size and Share by Breast Cancer 2022 - 2034
13.2 Lung Cancer
13.2.1 Global Cancer Diagnosis Revenue Market Size and Share by Lung Cancer 2022 - 2034
13.3 Colorectal Cancer
13.3.1 Global Cancer Diagnosis Revenue Market Size and Share by Colorectal Cancer 2022 - 2034
13.4 Melanoma
13.4.1 Global Cancer Diagnosis Revenue Market Size and Share by Melanoma 2022 - 2034
13.5 Other Cancers
13.5.1 Global Cancer Diagnosis Revenue Market Size and Share by Other Cancers 2022 - 2034
Chapter 14 Market Split by Technology Outlook: Analysis 2022 - 2034
14.1 IVD Testing
14.1.1 Global Cancer Diagnosis Revenue Market Size and Share by IVD Testing 2022 - 2034
14.2 Biopsy Technique
14.2.1 Global Cancer Diagnosis Revenue Market Size and Share by Biopsy Technique 2022 - 2034
14.3 Imaging
14.3.1 Global Cancer Diagnosis Revenue Market Size and Share by Imaging 2022 - 2034
Chapter 15 Market Split by End User Outlook: Analysis 2022 - 2034
15.1 Hospitals
15.1.1 Global Cancer Diagnosis Revenue Market Size and Share by Hospitals 2022 - 2034
15.2 Diagnostic Laboratories
15.2.1 Global Cancer Diagnosis Revenue Market Size and Share by Diagnostic Laboratories 2022 - 2034
Chapter 16 Research Findings
16.1 Key Takeaways
16.2 Analyst Point of View
16.3 Assumptions and Acronyms
Chapter 17 Research Methodology and Sources
17.1 Primary Data Collection
17.1.1 Steps for Primary Data Collection
17.1.1.1 Identification of KOL
17.1.2 Backward Integration
17.1.3 Forward Integration
17.1.4 How Primary Research Help Us
17.1.5 Modes of Primary Research
17.2 Secondary Research
17.2.1 How Secondary Research Help Us
17.2.2 Sources of Secondary Research
17.3 Data Validation
17.3.1 Data Triangulation
17.3.2 Top Down & Bottom Up Approach
17.3.3 Cross check KOL Responses with Secondary Data
17.4 Data Representation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us